chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm was itchy and she started scratching it; Red; Swollen under the skin at the injection site; Swollen circle the size of a tennis ball; Tender; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Feb-2021 and was forwarded to Moderna on 08-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tender), VACCINATION SITE PRURITUS (Arm was itchy and she started scratching it), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE SWELLING (Swollen under the skin at the injection site) and VACCINATION SITE MASS (Swollen circle the size of a tennis ball) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced TENDERNESS (Tender). On 07-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swollen under the skin at the injection site) and VACCINATION SITE MASS (Swollen circle the size of a tennis ball). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Arm was itchy and she started scratching it) and VACCINATION SITE ERYTHEMA (Red). At the time of the report, TENDERNESS (Tender), VACCINATION SITE PRURITUS (Arm was itchy and she started scratching it), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE SWELLING (Swollen under the skin at the injection site) and VACCINATION SITE MASS (Swollen circle the size of a tennis ball) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications used were not reported. No treatment information were reported.
heart afib, pounding heart, heart skipping, high blood pressure, high pulse rate. after receiving the first shot.  i have not received my second shot.  I have never had these problems before.
Fever 101.4 Chills Body aches  Nausea Headache Leg pain Fatigue Sweats
Can barely lift or use her arms; Raspy voice; Fatigue; Headache; Chills; Swelling in the arm at the injection site; Red swelling that is itchy; Red swelling that burns; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (Can barely lift or use her arms), DYSPHONIA (Raspy voice), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]), ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]), HYDROCHLOROTHIAZIDE, IRBESARTAN (AVALIDE), ATENOLOL (TENORMIN) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced MOVEMENT DISORDER (Can barely lift or use her arms), DYSPHONIA (Raspy voice), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills), VACCINATION SITE SWELLING (Swelling in the arm at the injection site), VACCINATION SITE PRURITUS (Red swelling that is itchy) and VACCINATION SITE PAIN (Red swelling that burns). At the time of the report, MOVEMENT DISORDER (Can barely lift or use her arms), DYSPHONIA (Raspy voice), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills), VACCINATION SITE SWELLING (Swelling in the arm at the injection site), VACCINATION SITE PRURITUS (Red swelling that is itchy) and VACCINATION SITE PAIN (Red swelling that burns) outcome was unknown.            No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Onset of difficulty breathing, lip swelling and itching approximately 15 hours after vaccination.  Tx in ER and initially diagnosed with suspected spider bite to upper arm (area proximal to L elbow, posterior arm).  Swelling and arm pain worsened and rechecked with ER and admitted to the hospital.  Necrosis to L posterior arm, proximal to elbow and rash to bil arms and legs.  Provider suspects Post vaccine purpura and immune complex induced macular popular rash.
rash on left upper arm with a lot of itching. Treated in Emergency Dept. with oral Atarax and oral benadryl, then discharged home when symptoms decreased.
2-16-07: vaccine administered  2-17-07: developed redness/swelling/local heat & discomfort 2-18-07:all same except local discomfort increasing  2-19-07: pain now radiating down arm and present with movement; induration measured - 60mm x 50mm (employee works at a hospital; employee health nurse there meaured the induration).  Applied ice x2, 2 ES Tylenol and benadryl taken.  2-20-07:  Notified me of reaction.  Per employee health nurse at the job location now, induration slightly larger.  I advised her to seek medical care from her doctor. This vaccine was given as part of an employee benefit .  She does not have the insurance that provides the benefit.     Manufacturer of vaccine is: Sanofi Pasteur Limited (Adacel)
This case was reported by a physician via call center representative and described the occurrence of injection site erythema in a 79-year-old female patient who received SHINGRIX (batch number B9739, expiry date November 2020) for prophylaxis. On 27th June 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 28th June 2018, 1 days after receiving SHINGRIX, the patient experienced injection site erythema, pain in arm and injection site induration. On an unknown date, the outcome of the injection site erythema and pain in arm were recovered/resolved and the outcome of the injection site induration was unknown. It was unknown if the reporter considered the injection site erythema, pain in arm and injection site induration to be related to SHINGRIX. Additional details were provided as follows: The caller was a nurse from healthcare professional office relaying information on behalf of provider. The caller relayed that the patient received SHINGRIX on left deltoid. The caller relayed that the patient complained of redness and hard area at the injection site that was initially about the size of a baseball but went to elbow. The caller also relayed that the patient complained of tenderness to the arm that felt like she ran into a wall. The caller relayed that the patient states the symptoms lasted several days and started the day after administration. The caller relayed that the patient had 2nd dose of SHINGRIX (batch number 7X3EJ, expiry date 13-October 2018) on right arm. No further information provided. This is 1 of the 3 linked cases reported by the same reporter.
Pt called clinic, c/o redness and blotching of the left upper arm with swelling.  Area was warm to touch and swollen from shoulder to the elbow. Pt also c/o fingers tingling.  Pt was given Prednisone 20 mg bid for five days per Dr.
This spontaneous report as received from a other health professional refers to an unspecified amount of patients of unknown age and gender. It was reported that an unspecified number of RECOMBIVAX HB vaccines were administered to unspecified patients on unspecified date. GARDASIL was involved in an unsupported temperature excursion in August 2013 (reported on 26-FEB-2013). No further information was available. The case is linked to 1302USA012759, 1303USA007275 and 1303USA007276 which respectively describe unsupported temperature excursion of vaccine, VAQTA, live, oral ROTATEQ and RECOMBIVAX HB. Additional information has been requested.
tingling in my left arm/tingling in my left hand; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in my left arm/tingling in my left hand) and VACCINATION SITE PAIN (pain at the injection site) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Sep-2021, the patient experienced PARAESTHESIA (tingling in my left arm/tingling in my left hand) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, PARAESTHESIA (tingling in my left arm/tingling in my left hand) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided.  No treatment medication provided.
This spontaneous report as received from a Medical Assistant refers to a group of 3 patients of unknown age. Medical history, current conditions and concomitant medication were not reported. On an unknown date (In September 2014), the patients were vaccinated with VARIVAX (Merck) (Lot # and expiration date were not provided). On an unknown date (In September 2014), 3 patients received improperly stored with VARIVAX (Merck). No symptoms reported. No other details. Additional information has been requested.
initial symptoms: chills, muscle aches, lethargy ongoing:  respiratory infection and/or inflammation acquired COVID twice post-vaccination, first in 1/2022 (within 3 months of "full" vaccination - had not acquired covid until post-vaccines), the second in 10/2022 - both were quite severe, but not requiring hospitalization, resulting in lasting chronic illness acquired multiple additional, undefined respiratory illnesses post-covid vaccinations ongoing respiratory infections and shortness of breath, chronic illness
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 17-JUL-2013, the patient was vaccinated with a expired dose of M-M-R II (Lot number was reported 1003AA, expiry date was 28-JUN-2013, dose and route were not reported). No adverse effects reported. Additional information has been requested.
Four hours after immunization patient developed shortness of breath and numbness in her fingers and lips. It lasted approximately 1/2 hour. No one was contacted and no treatment was necessary.
Symptoms began 24 hours after injection and lasted 24 hours; headache, body aches, fatigue
Sx: slight redness at (L) upper arm, no heat, no swelling. Redness about 22 mm in diameter at varicella vacc. site. Tx: ice packs.
Scheduled for his 2nd dose on 22Mar2021, only 20 days from his 1st dose.; This spontaneous case was reported by a consumer and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Scheduled for his 2nd dose on 22Mar2021, only 20 days from his 1st dose.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Scheduled for his 2nd dose on 22Mar2021, only 20 days from his 1st dose.). On 19-Mar-2021, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Scheduled for his 2nd dose on 22Mar2021, only 20 days from his 1st dose.) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Received SHINGRIX 50 mg/0.5 m injection on Tues. April 2. Arm swelled and hurt right away. Came down with shingles April 6, 2019. Saw dermatologist April 8, 2019 who confirmed shingles. The new SHINGRIX 50mg/0.5 m injection was to prevent shingles. I came down with shingles 5 days later and had to be treated with Valacyclovir by dermatologist.
RASH ON LEFT ARM AND BACK ITCHING TAKING ZYRTEC SYMPTOMS LESS ON 10.30.2017.
Arm pain / throbbing leg; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain / throbbing leg) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain / throbbing leg). At the time of the report, PAIN IN EXTREMITY (Arm pain / throbbing leg) outcome was unknown.            No concomitant medications were reported. Treatment information was not provided.
ABOUT 2 MONTHS AFTER VACCINATION PATIENT DEVELOPED ELEVATED BLOOD PRESSURE, JAW PAIN, CHEST PAIN AND BACK PAIN AND WENT TO THE ED. FROM THERE PATIENT WAS SENT TO DR. ON JULY 2, 2021 AND WILL PROBABLY NEED A PACEMAKER IN THE FUTURE.
Patient states right arm from elbow to shoulder is in severe pain with any movement. States pain level is a 4/10 scale at rest also. States progressively worse.
almost immediately after injection, numbness and tingling in left hand. Specifically, pinky, part of ring finger and part of palm. Feels like I hit my funny bone. No treatment so far. Feeling has persisted without change
No immediate adverse reactions.  About a month or two later noticed weakness in legs and weird tingling getting worse as the day went on.  Felt very unsteady when starting to walk.  Difficulty swallowing pills would get stuck in throat and I would have to cough it up and try again.  Back of throat feels swollen.  Sense of taste has diminished.  On and off during the day experience pins and needles in legs, hot cold sensations in legs.  Vision has been slightly altered
One week after vaccine, 4 - 5 inch red wheal over vaccination site, mild itching, mild discomfort, still there a week later
sore throat; lethargy; body ache; joint pain; temperature was 97.5'F; This is a spontaneous report from a contactable consumer. A 70-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 31Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.  The patient medical history and  concomitant medications were not reported. Patient previously received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 10Mar2021 for covid-19 immunization.The patient experienced sore throat, lethargy, body ache, joint pain, and temperature was 97.5'f in Apr2021.The patient underwent lab tests and procedures which included body temperature: 97.5 fahrenheit in Apr2021.  Outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient developed a self-limited bout of ischemic colitis sigmoid and descending colon confirmed by colonoscopy and biopsy
kicked his butt; This case was reported by a pharmacist and described the occurrence of feeling unwell in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient's pharmacy friend. The patient born about in 1966. The age at vaccination was not reported. The patient received Shingrix in year 2020. The reporter stated that the 2nd dose of Shingrix kicked the patient's butt. The reporter consented to follow up. No further information was available but agreeable to contact by email. This was 1 of 3 linked cases reported by the same reporter. Sender's Comments:  US-GLAXOSMITHKLINE-US2020246486:same reporter US-GLAXOSMITHKLINE-US2020246482:same reporter
Heart problems related to GARDASIL vaccine. My daughter has experienced severe heart palpation's. She has been diagnosed with Mitro Valve Prolapse and struggles with heart palpitations on an ongoing basis. She never had any of these problems prior to her getting the first shot of the vaccine. She is visiting a cardiologist to see what other problems there maybe with her heart. I feels all these symptoms started after her first dose of GARDASIL vaccine. I never made the connections and she has received all three of the series of shots. Until my daughter brought it up in a conversations about a friend of hers at school experienced a similar reaction to her heart after she received the GARDASIL did I finally realize there might be a connection to this drug.
Developed a big red bump on face which was about 5cm in diameter and was hard.; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Mar2021 at 09:30 (at the age of 19-years old) as a single dose for COVID-19 immunisation. Medical history included c diff (clostridium difficile infection). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Mar2021 at 11:00, about an hour and a half after first shot, the patient developed a big red bump on face which was about 5cm in diameter and was hard. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event a big red bump on face was recovered on an unknown date in Mar2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Severe localized reaction.  Her caretaker took her to her DR who said it was from the Pneumovax vaccine.  The reaction did subside with time.
HR was 130 and she reported she felt lightheaded when in office, She had her buspar w/ her and nurse advised her to take this. She then layed down for another 20 minutes due to dizziness. She asked if she could walk around and call her husband, which lasted about another 30 minutes, nurse told her she could while watching pt   She was doing well when she left. HR was about 100-115. Another nurse and the PA on site checked her before she left the building
Unilateral sudden hearing loss, left ear. Normal tympanogram, normal temporal CT. No headache, visual change, dizziness, otalgia, tinnitus. Symmetrical facial movements. Exam was consistent with conductive hearing loss. Was referred to ENT, started on corticosteroids. Outcome undetermined.
Patient not feeling well, low grade temp, gave Tylenol; patient deltoid warm to touch, no inflammation; not red - patient to continue using ice, Tylenol and Benadryl.
Swollen lips hives gave BENADRYL - helped, hives better, swelling down.
Site: Pain at Injection Site-Medium, Systemic: Allergic: Anaphylaxis-Mild, Systemic: Cardiac Disorder (diagnosed by MD)-Mild, Systemic: Joint Pain-Medium
muscle in the crock of my arm is swollen; This is a spontaneous report from a contactable consumer or other non hcp. A 79-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in Arm Left on 28Jan2021 17:00 (Batch/Lot Number: EN9581) as SINGLE DOSE for covid-19 immunisation. Medical history included non-hodgkin's lymphoma Mother with non-hodgkin's lymphoma. It was reported that patient had the Pfizer first dose a week ago today. She did not have a specific reaction but the muscle in her arm, the crook of her arm, is swollen. She didn't know if this was a side effect of the vaccine or not. Clarifies she received the first dose of the Pfizer COVID 19 vaccine 28Jan2021 1700PM in the left arm. She noticed maybe about five days after the vaccine, noticed the swelling in her arm by the muscle in the crook of her arm. She is unsure if she pulled her arm. Mentions she does not have lymphedema. She is scheduled 18Feb2021 for the second dose. Patient states height is 5 foot 1 inch or 5 foot tall. She used to be 5 foot 2 inches; states she shrunk from natural aging. Outcome of the event was recovering.
Severe arm pain; numbness and tingling in left arm; tingling in left arm; night chill/sweats; night chill/sweats; fever 100.1; headache; feeling unwell; This is a spontaneous report from a contactable other hcp (Nurse) (patient). A 35-year-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6201) via an unspecified route of administration, administered in arm left on 23Feb2021 16:30 (at the age of 35-year-old) at dose 1, single for covid-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. Other medications in two weeks: Sprinters. Patient had no known allergies. Patient did not have other vaccine in four weeks. Patient did not have covid prior vaccination. Patient was not tested for covid post vaccination. On 24Feb2021 16:00 the patient experienced severe arm pain, numbness and tingling in left arm, night chill/sweats, fever 100.1, headache, feeling unwell. The patient underwent lab tests and procedures which included fever: 100.1 on an unspecified date. Patient did not receive treatment for the adverse events. Outcome of the events was not resolved.   Follow-up (25May2021): Follow-up attempts completed. No further information expected
"Cried for 3 d"; cried for more than 3 hrs straight without sleep or feedings per mom's report.
Patient's wife called today to inform us that her husband passed away on 04/17/2021. Patient experienced some side effects after receiving both doses of Moderna vaccine such as body ache and feeling of lethargy. Patient was taken to the hospital around 04/16/2021. Exact cause of the death is not known as wife did not want to get autopsy done.